Category: medical cannabis

World Health Organization Explores International Rescheduling of CBD at Expert Committee Meeting

by Todd | Oct 26, 2017 | General, Medical Cannabis, Pharma & Biotech, Research | 0 comments October 26, 2017 Raul Elizalde to speak before WHO Expert Committee on Drug Dependence review of the psychoactivity of CBD. On November 6th, the World Health Organization’s (WHO) Thirty-Ninth meeting of the Expert Committee on Drug Dependence will begin a 5-day agenda set to determine the potential for harm or dependance of 16 different substances, including cannabidiol (CBD). Medical Marijuana, Inc. subsidiary HempMeds® will have a representative speaking before the committee on the first day regarding CBD. While WHO recognizes the medical use of certain substances is indispensable in the treatment of many conditions and that they should be available to patients for such purposes, the committee is also tasked with determining which substances should be regulated or banned internationally as scheduled drugs. WHO has a part in two of the United Nation’s central drug control conventions – the 1961 Single Convention on Narcotic Drugs and 1971 Convention on Psychotropic substances. WHO is responsible for conducting the medical, scientific, and public health evaluation of potentially harmful substances to determine the UN’s role in regulating them. This is done through the thirteen member Expert Committee on Drug Dependence (ECDD). The committee is made up of an international panel of experts in the field of drug addiction and abuse. The ECDD evaluates the dependence-producing...

Read More

Study: Retail Cannabis Sales Associated With Fewer Opioid Deaths

SHARE THIS POST Thursday, 19 October 2017 Fort Worth, TX: Retail cannabis distribution in Colorado is associated with a reduction in opioid-related mortality, according to data published online ahead of print in The American Journal of Public Health. A team of investigators from the University of North Texas School of Public Health, the University of Florida, and Emory University compared changes in the prevalence of monthly opioid-related deaths before and after Colorado retailers began selling cannabis to adults. Researchers compared Colorado’s data with trends in neighboring states (that had not implemented any change in marijuana’s legal status), and also sought to control for recent changes in the state’s prescription drug monitoring program. Authors reported a 6.5 percent decrease in monthly opioid deaths following retail cannabis sales. They wrote: “Colorado’s legalization of recreational cannabis sales and use resulted in a 0.7 deaths per month reduction in opioid-related deaths. This reduction represents a reversal of the upward trend in opioid-related deaths in Colorado.” Authors concluded, “Legalization of cannabis in Colorado was associated with short-term reductions in opioid-related deaths.” Their data is consistent with prior studies finding that cannabis access is associated with reductions in prescription drug spending, opioid-related hospitalizations, and opioid-related fatalities. For more information, contact Paul Armentano, NORML Deputy Director, at Full text of the study, “Recreational cannabis legalization and opioid-related deaths in Colorado, 2000-2015,” appears in The American...

Read More

Great Grandson of Anheuser-Busch Founder Calls for Medical Cannabis Legalization in Missouri

Getty From Publix Supermarkets to NASCAR, and the obvious pharmaceutical companies, we’ve seen a ridiculously large amount of pushback from various U.S. corporations taking a stand against the outright legalization of medical cannabis nationwide. With this in mind, it’s great to see corporate elites come out in favor of legal cannabis – in whatever fashion. That’s exactly what Adolphus Busch IV recently did. Busch, the heir to the throne of the Anheuser-Busch beer conglomerate, has been gaining support for medical cannabis legalization in the state of Missouri. Busch is the great-grandson of the founder of the beer corporation. Busch...

Read More

Tilray to Build $24 Million Medical Cannabis Cultivation and Processing Facility in Portugal

Tilray, a federally licensed cannabis producer based in British Columbia, recently announced plans to build a €20 million ($24 million) European campus in Portugal to cultivate, process, package, and distribute GMP-grade medical cannabis products to qualified patients, pharmacies, and researchers throughout the European common market. “Tilray’s EU campus is another strategic milestone as we aim to build the world’s most trusted and admired medical cannabis brand,” said Brendan Kennedy, Chief Executive Officer of Tilray.   The 270,000 square foot campus will be located in the BIOCANT Research Park in Cantanhede, Portugal and will be constructed in phases over the...

Read More

The American Legion Urges the Federal Government to Give Veterans Access to Medical Cannabis

Getty We’ve reported in the past about the potential effectiveness of medical cannabis use for military veterans suffering from PTSD. As that issue slowly but surely progresses forward, some members of the American Legion are starting to take more drastic action. Last year, the organization called for the federal government to reschedule cannabis as a Schedule 1 drug. Unfortunately, that hasn’t yet come to pass, as the absurd Schedule 1 classification remains. Recently, the American Legion published a resolution that urges the federal government to give Department of Veterans Affairs doctors the ability to recommend cannabis in states where...

Read More


FOR IMMEDIATE RELEASE COMI-CON DAY ONE – BUDTRADER.COM THROWS A RAGER   WARNED BY BOTH MARINA POLICE AND EVENT ORGANIZERS TO “SLOW THEIR ROLL” SAN DIEGO, CA – July 21, 2017 –, the nation’s largest online platform for the legal cannabis industry is the talk Comi-Con San Diego after the first day of the iconic event. Hosting a weekend-long Comic-Con party on their “Superyacht” BudTrader Liquidity, they’ve received two warnings from the Marina Police and one from Comi-Con organizers for the energetic party. Sandwiched between the IMDB and Turner yachts, the BudTrader boat is a huge hit (no pun intended). Located at the exclusive 5th Avenue Landing (immediately behind the San Diego Convention Center) where the annual event is held, BudTrader had guests from the two neighboring yachts looking over the sides wantingly. At one point, Paul Verra  BudTrader’s director of promotions felt bad and brought a couple of the IMDB guys aboard for a tour, introductions to the BudTrader Babes and a little partying. 5th Avenue Landing Staff the slips are usually booked up to 1 year in advance and are typically reserved for Hollywood Movie Studios and Media Conglomerates, but due to a last minute cancellation, Brad McLaughlin, CEO of BudTrader was able to sneak in under the radar with less that 7 days to plan his shananigans, The weekend-long party is accessible by invite only....

Read More
  • 1
  • 2